The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Hospital Mater Dei's share price is R$4.88.
Hospital Mater Dei's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was R$1,736.75. Hence, Hospital Mater Dei's PS Ratio for today is 0.00.
The historical rank and industry rank for Hospital Mater Dei's PS Ratio or its related term are showing as below:
During the past 9 years, Hospital Mater Dei's highest PS Ratio was 8.50. The lowest was 0.60. And the median was 1.78.
BSP:MATD3's PS Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.47 * Ranked among companies with meaningful PS Ratio only.
During the past 12 months, the average Revenue per Share Growth Rate of Hospital Mater Dei was 17.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 25.40% per year.
During the past 9 years, Hospital Mater Dei's highest 3-Year average Revenue per Share Growth Rate was 38.80% per year. The lowest was 11.90% per year. And the median was 24.20% per year.
Back to Basics: PS Ratio
Hospital Mater Dei (BSP:MATD3) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Hospital Mater Dei PS Ratio Related Terms
Hospital Mater Dei PS Ratio Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Hospital Mater Dei's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's PS Ratio distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Hospital Mater Dei's Share Price of today is R$4.88. Hospital Mater Dei's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1,736.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Hospital Mater Dei (BSP:MATD3) has a PS Ratio of 0.00 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hospital Mater Dei and its competitors. Over the past decade, Hospital Mater Dei's PS Ratio has ranged from 0.60 to 8.50. According to the industry distribution chart, Hospital Mater Dei ranks #197 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 29.8%.
Is Hospital Mater Dei's PS Ratio too high?
Hospital Mater Dei's current PS Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 8.50. Based on the distribution chart, Hospital Mater Dei ranks #197 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #197 out of 662 companies for PS Ratio. This puts Hospital Mater Dei in the upper half of its industry. The industry median PS Ratio is 1.47. Historically, Hospital Mater Dei's own PS Ratio has ranged from 0.60 to 8.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current PS Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Possible Value Trap. The stock's GF Value™ is R$2,813.62, compared to a current price of R$4.88 — trading 99.8% below its estimated fair value. The current PS Ratio is 0.00. Hospital Mater Dei's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current PS Ratio is 0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.88 is trading 99.8% below its estimated GF Value™ of R$2,813.62.
GuruFocus considers Hospital Mater Dei to be Possible Value Trap.
Key valuation signals for BSP:MATD3:
PS Ratio: 0.00
GF Value™: R$2,813.62 vs. price of R$4.88 (99.8% below fair value)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
75GF Score
Get the complete analysis for BSP:MATD3
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
